A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin (LTLD, ThermoDox) and Magnetic Resonance-Guided High Intensity Focused Ultrasound (MR-HIFU) for Relapsed or Refractory Solid Tumors in Children, Adolescents, and Young Adults
Phase of Trial: Phase I
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Doxorubicin (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 02 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 26 Oct 2016 Status changed from not yet recruiting to recruiting.
- 12 May 2016 Planned initiation date changed from 1 Oct 2015 to 1 Jul 2016.